Tehran University of Medical Sciences

Science Communicator Platform

Share By
Cell Transfer-Based Immunotherapies in Cancer: A Review Publisher Pubmed



Gorabi AM1 ; Hajighasemi S2 ; Sathyapalan T3 ; Sahebkar A4, 5, 6
Authors

Source: IUBMB Life Published:2020


Abstract

In cell transfer therapy (CTT), immune cells such as innate immune-derived natural killer cells and dendritic cells as well as acquired immune-related T lymphocytes such as tumor-infiltrating lymphocytes and cytokine-activated or genetically modified peripheral blood T cells are used in the management of cancer. These therapies are increasingly becoming the most used treatment modality in cancer after tumor resection, chemotherapy, and radiotherapy. In adoptive cell transfer, the lymphocytes isolated from either a donor or the patient are modified ex vivo and reinfused to target malignant cells. Transferring in vitro-manipulated immune cells produces a continuous antitumor immune response. In this review, we evaluate the recent advances in CTT for the management of various malignancies. © 2019 International Union of Biochemistry and Molecular Biology
Related Docs
View other Related Docs
1. New Approaches in Cancer Immunotherapy: Review Article, Tehran University Medical Journal (2018)
2. Car-T Cells: Early Successes in Blood Cancer and Challenges in Solid Tumors, Acta Pharmaceutica Sinica B (2021)
3. Recent Progress in Cancer Immunotherapy: Overview of Current Status and Challenges, Pathology Research and Practice (2023)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (4)
Hamid Reza Mirzaei (3)
Other Related Docs
4. Tumor-Associated Macrophages, Nanomedicine and Imaging: The Axis of Success in the Future of Cancer Immunotherapy, Immunotherapy (2017)
5. Tumor-Draining Lymph Node-Targeted Electrochemotherapy: A Hypothesis for in Situ Cancer Vaccination, Biomedicines (2025)
6. Immunotherapeutic Approaches for Cancer Therapy: An Updated Review, Artificial Cells# Nanomedicine and Biotechnology (2016)
7. Concomitant Blockade of A2ar and Ctla-4 by Sirna-Loaded Polyethylene Glycol-Chitosan-Alginate Nanoparticles Synergistically Enhances Antitumor T-Cell Responses, Journal of Cellular Physiology (2020)
8. Abscopal Effect in Radioimmunotherapy, International Immunopharmacology (2020)
9. Cancer Immunotherapy: Diverse Approaches and Obstacles, Current Pharmaceutical Design (2022)
10. Optimizing Cancer Treatment: The Synergistic Potential of Car-T Cell Therapy and Crispr/Cas9, Frontiers in Immunology (2024)
11. Anti-Ctla-4 Nanobody As a Promising Approach in Cancer Immunotherapy, Cell death & disease (2024)
12. Nanoparticles and Targeted Drug Delivery in Cancer Therapy, Immunology Letters (2017)
13. Cancer Immunotherapy Confers a Global Benefit, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
14. Blockade of Ctla-4 Increases Anti-Tumor Response Inducing Potential of Dendritic Cell Vaccine, Journal of Controlled Release (2020)
15. Cancer Immunotherapy Confers a Global Benefit, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2015)
16. Cancer Exosomes and Natural Killer Cells Dysfunction: Biological Roles, Clinical Significance and Implications for Immunotherapy, Molecular Cancer (2022)
17. Gene Therapy and Genetic Vaccines, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
18. Biogenic Selenium Nanoparticles Potentiate Anti-Mesothelin Car-T Cell Therapy in a Syngeneic Tnbc Model, Transplantation and Cellular Therapy (2026)
19. Genetically Modified Immune Cells Targeting Tumor Antigens, Pharmacology and Therapeutics (2020)
20. Cancer Stem Cell-Targeted Chimeric Antigen Receptor (Car)-T Cell Therapy: Challenges and Prospects, Acta Pharmaceutica Sinica B (2021)